from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1177/fdxC

LFCtreatmentdescriptionclass of inhibitor

1.664

Amikacinug/mL Amikacintranslation

1.477

Cap5-10ug/mL Capreomycintranslation

0.967

Rox10-50 ug/mL Roxithromycintranslation

1.019

SM2-5 ug/mL Streptomycintranslation

0.766

Tet5-10 ug/mL Tetracyclinetranslation

-1.767

Rif0.2-5ug/mL Rifampicintranscription

-0.503

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.372

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.102

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.432

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.772

Clofazimine10-13 ug/mL Clofaziminerespiration

0.290

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.248

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.990

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.273

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.495

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.660

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.020

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.095

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.525

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.255

KCN5-20 ug/mL Potassium cyaniderespiration

0.319

NaN30.2-2 mM Sodium aziderespiration

-1.216

Nigericin50 uM Nigericinrespiration

-1.480

TRC10-150 ug/mL Triclosanrespiration

-1.140

TRZ10-25 ug/mL Thioridazinerespiration

0.947

Valinomycin0.5-10 uM Valinomycinrespiration

0.332

ZnSO42 mM ZnSO4respiration

0.891

menadione6-10 ug/mL Menadionerespiration

-0.664

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.007

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.658

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.520

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.304

NRP_1Non-replicating persistence stage 1dosRassociated

0.400

Amp0.2mg/mL AmpicillincellWall

0.251

Cephalexin20-100 ug/mL CephalexincellWall

-0.069

Cerulenin0.32-5 ug/mL CerulenincellWall

0.174

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.406

EMB10-20 ug/mL EthambutolcellWall

0.573

Eta12-40 ug/mL EthionamidecellWall

0.967

INH0.2-0.4 ug/mL IsoniazidcellWall

0.794

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.126

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.014

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.457

BZA0.12 mg/mL BenzamidearomaticAmides

0.788

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.858

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.366

H2O24 mM hydrogen peroxideDNAdamaging

0.853

Levo10 ug/mL LevofloxacinDNAdamaging

0.345

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.947

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.076

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.362

UVUV-irradiationDNAdamaging

-0.272

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.096

Antimycin12.5-50 ug/mL Antimycin A?

-0.299

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.260

PA_110-50 ug/mL Antitubercular compound PA-1?

0.469

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.306

PA8240.2-2 ug/mL PA-824?

1.082

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.017

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.092

Verapamil50 uM Verapamil?

-0.828

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.425

methoxatin10-20 ug/mL Methoxatin?